US Patent

US11638697 — Solid oral sulfate salt formulations for cleaning a colon and methods of using same

Formulation · Assigned to Braintree Laboratories Inc · Expires 2037-08-04 · 11y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects solid oral dosage formulations containing sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon.

USPTO Abstract

Disclosed herein are solid oral dosage formulations comprising sodium sulfate, magnesium sulfate, and potassium chloride for inducing purgation of the colon of a subject. Furthermore, the disclosed compositions and formulations are useful to cleanse the colon when administered in sufficient quantities. Methods for inducing purgation of the colon and for cleansing the colon are also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
US11638697
Jurisdiction
US
Classification
Formulation
Expires
2037-08-04
Drug substance claim
No
Drug product claim
Yes
Assignee
Braintree Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.